1. 1-24 of 745 1 2 3 4 ... 29 30 31 »
    1. eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors

      eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors

      eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today announced the appointment of accomplished financial executive, Bradford Smith, Chief Financial Officer (CFO) of Homology Medicines, Inc., as an independent member of the Board of Directors...

      Read Full Article
    2. AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

      AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

      AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today the appointment of James Corbett and Jan Stern Reed to its Board of Directors...

      Read Full Article
    3. Five Star Bank Announces Election of James Beckwith as Chairman of the Board of Directors of Western Bankers Association

      Five Star Bank Announces Election of James Beckwith as Chairman of the Board of Directors of Western Bankers Association

      RANCHO CORDOVA, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), and its subsidiary, Five Star Bank (the “Bank”) announce the election of James Beckwith, President and Chief Executive Officer of Five Star Bank, to the Board of Directors...

      Read Full Article
      Mentions: Nasdaq Bank Board
    4. Derrell D. Porter, M.D., Elected to Board of Directors of Passage Bio

      Derrell D. Porter, M.D., Elected to Board of Directors of Passage Bio

      PHILADELPHIA, June 01, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced the election of Derrell D. Porter, M.D., to its board of directors...

      Read Full Article
    5. ObsEva Announces Proposed Changes to the Composition of its Board of Directors

      ObsEva Announces Proposed Changes to the Composition of its Board of Directors

      ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that its Board of Directors will propose the election at the 2021 Annual General Meeting of Shareholders to be held on May 28, 2021 of Anne VanLent as member of the Board of Directors...

      Read Full Article
      Mentions: Nasdaq Women Board
    6. Turning Point Therapeutics Names Former Celgene Chairman and CEO, Mark Alles, to Chair Its Board of Directors

      Turning Point Therapeutics Names Former Celgene Chairman and CEO, Mark Alles, to Chair Its Board of Directors

      SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the appointment of former Celgene chairman and CEO, Mark Alles, to chair its board of directors...

      Read Full Article
    7. Longeveron Announces the Appointment of Ursula Ungaro to its Board of Directors

      Longeveron Announces the Appointment of Ursula Ungaro to its Board of Directors

      MIAMI, May 25, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today that Ursula Ungaro will be joining its Board of Directors...

      Read Full Article
    8. Codiak BioSciences Appoints Anne-Virginie Eggimann, M.Sc., to Board of Directors

      Codiak BioSciences Appoints Anne-Virginie Eggimann, M.Sc., to Board of Directors

      CAMBRIDGE, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, announced today it has appointed Anne-Virginie Eggimann, M.Sc., to its board of directors...

      Read Full Article
    1-24 of 745 1 2 3 4 ... 29 30 31 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content